mRNA-based COVID-19 vaccines appear not to increase immune events in cancer patients receiving immune checkpoint inhibitors

被引：2
作者：
Yekeduz, Emre [1 ,2 ]
Ayasun, Ruveyda [2 ,3 ]
Koksoy, Elif Berna [1 ,2 ]
Utkan, Gungor [1 ,2 ]
Urun, Yuksel [1 ,2 ]
Akbulut, Hakan [1 ,2 ]
机构：
[1] Ankara Univ, Dept Med Oncol, Ankara, Turkey
[2] Ankara Univ, Canc Res Inst, Ankara, Turkey
[3] Hacettepe Univ, Dept Med Oncol, Canc Inst, Ankara, Turkey
来源：
FUTURE VIROLOGY | 2021年 / 16卷 / 09期
关键词：
cancer; COVID-19; immunotherapy; mRNA; SARS-CoV-2; vaccine; INFLUENZA VACCINATION; SAFETY; IMMUNOGENICITY;
D O I：
10.2217/fvl-2021-0166
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：583 / 585
页数：3
相关论文
共 50 条
[41]   Immune checkpoint inhibitors for cancer and venous thromboembolic events [J].
Gong, Jingyi ;
Drobni, Zsofia D. ;
Alvi, Raza M. ;
Murphy, Sean P. ;
Sullivan, Ryan J. ;
Hartmann, Sarah E. ;
Gilman, Hannah K. ;
Lee, Hang ;
Zubiri, Leyre ;
Raghu, Vineet K. ;
Karp-Leaf, Rebecca S. ;
Zafar, Amna ;
Zlotoff, Daniel A. ;
Frigault, Matthew J. ;
Reynolds, Kerry L. ;
Neilan, Tomas G. .
EUROPEAN JOURNAL OF CANCER, 2021, 158 :99-110
[42]   Comparison of humoral immune response in heterologous and homologous COVID-19 booster vaccine groups using CoronaVac and mRNA-based BNT162b2 vaccines [J].
Atici, Serkan ;
Soysal, Ahmet ;
Gonullu, Erdem ;
Aydemir, Gokhan ;
Oner, Naci ;
Alan, Servet ;
Engin, Havva ;
Yildiz, Melek ;
Karabocuoglu, Metin .
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2023, 56
[43]   Immune Checkpoint Inhibitors and Atherosclerotic Vascular Events in Cancer Patients [J].
Inno, Alessandro ;
Chiampan, Andrea ;
Lanzoni, Laura ;
Verze, Matteo ;
Molon, Giulio ;
Gori, Stefania .
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
[44]   Pneumonitis from immune checkpoint inhibitors and COVID-19: current concern in cancer treatment [J].
Rossi, Ernesto ;
Schinzari, Giovanni ;
Tortora, Giampaolo .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
[45]   Do checkpoint inhibitors compromise the cancer patients' immunity and increase the vulnerability to COVID-19 infection? [J].
Kattan, Joseph ;
Kattan, Clarisse ;
Assi, Tarek .
IMMUNOTHERAPY, 2020, 12 (06) :351-354
[46]   Effects of immune related adverse events and corticosteroids on the outcome of patients treated with immune checkpoint inhibitors [J].
Sen, Gulin Alkan ;
Oztas, Nihan Senturk ;
Degerli, Ezgi ;
Safarov, Shamkhal ;
Guliyev, Murad ;
Bedir, Sahin ;
Can, Gunay ;
Turna, Hande ;
Ozguroglu, Mustafa .
SCIENTIFIC REPORTS, 2025, 15 (01)
[47]   Effect of age on the risk of immune-related adverse events in patients receiving immune checkpoint inhibitors [J].
Yang, Kaili ;
Li, Jiarui ;
Sun, Zhao ;
Bai, Chunmei ;
Zhao, Lin .
CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (07) :3907-3918
[48]   Oral manifestations of immune-related adverse events in cancer patients treated with immune checkpoint inhibitors [J].
Klein, Brittany A. ;
Alves, Fabio Abreu ;
de Santana Rodrigues Velho, Julia ;
Vacharotayangul, Piamkamon ;
Hanna, Glenn J. ;
LeBoeuf, Nicole R. ;
Shazib, Muhammad Ali ;
Villa, Alessandro ;
Woo, Sook-Bin ;
Sroussi, Herve ;
Sonis, Stephen ;
Treister, Nathaniel S. .
ORAL DISEASES, 2022, 28 (01) :9-22
[49]   Mechanisms Driving Immune-Related Adverse Events in Cancer Patients Treated with Immune Checkpoint Inhibitors [J].
Lee, David J. ;
Lee, Howard J., Jr. ;
Farmer, Jocelyn R. ;
Reynolds, Kerry L. .
CURRENT CARDIOLOGY REPORTS, 2021, 23 (08)
[50]   Genetic determinants of immune-related adverse events in patients with melanoma receiving immune checkpoint inhibitors [J].
Abdel-Wahab, Noha ;
Diab, Adi ;
Yu, Robert K. ;
Futreal, Andrew ;
Criswell, Lindsey A. ;
Tayar, Jean H. ;
Dadu, Ramona ;
Shannon, Vickie ;
Shete, Sanjay S. ;
Suarez-Almazor, Maria E. .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (07) :1939-1949
12345